How do antidepressants work? New perspectives for refining future treatment approaches.
Most currently available antidepressants target monoamine neurotransmitter function. However, a purely neurotransmitter-based explanation for antidepressant drug action is challenged by the delayed clinical onset of most agents and the need to explain how neurochemical changes reverse the many different symptoms of depression. Novel approaches to understanding of antidepressant drug action include a focus on early changes in emotional and social processing and the role of neural plasticity. In this Review, we discuss the ways in which these two different theories reflect different or complementary approaches, and how they might be integrated to offer novel solutions for people with depression. We consider the predictions made by these mechanistic approaches for the stratification and development of new therapeutics for depression, and the next steps that need to be made to facilitate this translation of science to the clinic.
University Department of Psychiatry, University of Oxford, Oxford, UK. Electronic address: catherine.harmer@psych.ox.ac.uk.
Catherine J
CJ
Harmer
Department of Psychiatry, Yale School of Medicine, Yale University, New Haven, CT, USA.
Ronald S
RS
Duman
University Department of Psychiatry, University of Oxford, Oxford, UK.
Philip J
PJ
Cowen
D000928:Antidepressive Agents / Q000494:pharmacology*; D003863:Depression / Q000188:drug therapy*; D004644:Emotions; D006801:Humans; D009473:Neuronal Plasticity; D012919:Social Behavior
D000928:Antidepressive Agents